Subscribe free to our newsletters via your
  Space Travel News  

Subscribe free to our newsletters via your

Discovery Carries Vaccine Research Along With ISS Equipment

Staphylococcus aureus.
by Staff Writers
Austin TX (SPX) Aug 25, 2009
Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines.

Specifically, research will be conducted on Staphylococcus aureus and Salmonella microbes in search of a potential target for a therapeutic agent or vaccine candidate. These bacterial microbes are known to cause hundreds of thousands of medically diagnosed infections every year around the world.

Astrogenetix has worked closely with NASA to fully utilize the International Space Station, one of NASA's primary priorities. The Company has flown on five shuttle missions performing drug development in microgravity since its formation in early 2008, has been designated a National Lab Pathfinder and is slated to fly on all remaining shuttle missions.

"Through our unique Vaccine Processing Platform, we hope to discover new medicines in space that will benefit lives on Earth," said John Porter, chief executive officer of Astrogenetix, and senior vice president and chief financial officer of parent company Astrotech Corporation.

When operated in microgravity, the Astrogenetix Vaccine Processing Platform dramatically reduces time-to-vaccine discovery because microgravity elicits unique interactions in biological systems that do not occur in terrestrial laboratories.

Returning samples from this flight will be examined and added to Astrogenetix's growing database of biomarker research. Post-flight analysis will immediately ensue at terrestrial labs in search of specific drug candidates gleaned from the results.

"We're really on the forefront of something big here," said Thomas B. Pickens III, Astrotech's chief executive officer and chairman of the board. "We have an acclaimed space science team, combined with the world's most advanced technology, to lead the field of medical discovery into the next frontier."

Astrogenetix, Inc. was formed by Astrotech Corp. to commercialize biotechnology products processed in the unique environment of microgravity. Over the last 25 years, Astrotech Corp. has supported the launch of 23 shuttle missions and more than 260 spacecraft, built space hardware and processing facilities, and prepared and processed scientific research for microgravity.

Share This Article With Planet Earth DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook

Related Links
Shuttle at NASA
Watch NASA TV via Space.TV
Space Shuttle News at Space-Travel.Com

Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News

Discovery gets the all-clear for Tuesday launch of international crew
Washington (AFP) Aug 23, 2009
NASA gave a final green light to continue the countdown to the launch of the shuttle Discovery Tuesday toward the International Space Station, carrying a crew of seven including a Swede. Mission officials said at a press briefing Sunday they saw no likely technical hurdles to takeoff August 25 at 0136 am (0536 GMT) from Kennedy Space Center in Cape Canaveral, Florida. ... read more

The content herein, unless otherwise known to be public domain, are Copyright 1995-2009 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement